Apyx Medical Yönetim
Yönetim kriter kontrolleri 3/4
Apyx Medical CEO'su Charlie Goodwin, Dec2017 tarihinde atandı, in görev süresi 6.92 yıldır. in toplam yıllık tazminatı $ 1.26M olup, şirket hissesi ve opsiyonları dahil olmak üzere 38.2% maaş ve 61.8% ikramiyelerden oluşmaktadır. şirketin hisselerinin 0.26% ine doğrudan sahiptir ve bu hisseler $ 105.30K değerindedir. Yönetim ekibinin ve yönetim kurulunun ortalama görev süresi sırasıyla 5.8 yıl ve 6.8 yıldır.
Anahtar bilgiler
Charlie Goodwin
İcra Kurulu Başkanı
US$1.3m
Toplam tazminat
| CEO maaş yüzdesi | 38.2% |
| CEO görev süresi | 6.9yrs |
| CEO sahipliği | 0.3% |
| Yönetim ortalama görev süresi | 5.8yrs |
| Yönetim Kurulu ortalama görev süresi | 6.8yrs |
Son yönetim güncellemeleri
Recent updates
Is There An Opportunity With Apyx Medical Corporation's (NASDAQ:APYX) 41% Undervaluation?
Sep 14
Apyx Medical Corporation (NASDAQ:APYX) Stock's 25% Dive Might Signal An Opportunity But It Requires Some Scrutiny
Aug 07We Discuss Why Apyx Medical Corporation's (NASDAQ:APYX) CEO Compensation May Be Closely Reviewed
Aug 01Is Apyx Medical (NASDAQ:APYX) Using Debt In A Risky Way?
Jun 19Revenues Working Against Apyx Medical Corporation's (NASDAQ:APYX) Share Price Following 25% Dive
Apr 18Apyx Medical Corporation (NASDAQ:APYX) Analysts Just Slashed This Year's Estimates
Mar 26Take Care Before Diving Into The Deep End On Apyx Medical Corporation (NASDAQ:APYX)
Feb 16Is Apyx Medical (NASDAQ:APYX) A Risky Investment?
Sep 14Does Apyx Medical (NASDAQ:APYX) Have A Healthy Balance Sheet?
Jun 07Forecast: Analysts Think Apyx Medical Corporation's (NASDAQ:APYX) Business Prospects Have Improved Drastically
Mar 21Here's Why We're Watching Apyx Medical's (NASDAQ:APYX) Cash Burn Situation
Dec 14We're Not Very Worried About Apyx Medical's (NASDAQ:APYX) Cash Burn Rate
Aug 30Apyx Medical GAAP EPS of -$0.16 beats by $0.03, revenue of $10.3M misses by $0.26M
Aug 11Apyx Medical gets FDA nod for Renuvion's use in improving loose skin on neck, chin
Jul 18CEO Tazminat Analizi
| Tarih | Toplam Tazminat | Maaş | Şirket Kazançları |
|---|---|---|---|
| Jun 30 2024 | n/a | n/a | -US$28m |
| Mar 31 2024 | n/a | n/a | -US$23m |
| Dec 31 2023 | US$1m | US$483k | -US$19m |
| Sep 30 2023 | n/a | n/a | -US$15m |
| Jun 30 2023 | n/a | n/a | -US$16m |
| Mar 31 2023 | n/a | n/a | -US$21m |
| Dec 31 2022 | US$2m | US$483k | -US$23m |
| Sep 30 2022 | n/a | n/a | -US$19m |
| Jun 30 2022 | n/a | n/a | -US$18m |
| Mar 31 2022 | n/a | n/a | -US$16m |
| Dec 31 2021 | US$2m | US$450k | -US$15m |
| Sep 30 2021 | n/a | n/a | -US$15m |
| Jun 30 2021 | n/a | n/a | -US$14m |
| Mar 31 2021 | n/a | n/a | -US$15m |
| Dec 31 2020 | US$2m | US$450k | -US$12m |
| Sep 30 2020 | n/a | n/a | -US$16m |
| Jun 30 2020 | n/a | n/a | -US$16m |
| Mar 31 2020 | n/a | n/a | -US$16m |
| Dec 31 2019 | US$2m | US$450k | -US$20m |
| Sep 30 2019 | n/a | n/a | -US$18m |
| Jun 30 2019 | n/a | n/a | -US$15m |
| Mar 31 2019 | n/a | n/a | -US$14m |
| Dec 31 2018 | US$1m | US$400k | -US$11m |
| Sep 30 2018 | n/a | n/a | -US$10m |
| Jun 30 2018 | n/a | n/a | -US$12m |
| Mar 31 2018 | n/a | n/a | -US$15m |
| Dec 31 2017 | US$2m | US$15k | -US$14m |
Tazminat ve Piyasa: Charlie 'nin toplam tazminatı ($USD 1.26M ), US pazarındaki benzer büyüklükteki şirketler için ortalamanın üzerindedir ($USD 654.40K ).
Tazminat ve Kazançlar: Charlie 'in tazminatı, şirketin son bir yıldaki performansıyla tutarlıydı.
CEO
Charlie Goodwin (58 yo)
6.9yrs
Görev süresi
US$1,261,470
Tazminat
Mr. Charles D. Goodwin II, also known as Charlie, has been Chief Executive Officer and Director of Apyx Medical Corporation (formerly known as Bovie Medical Corporation) since December 15, 2017 and serves...
Liderlik Ekibi
| İsim | Pozisyon | Görev süresi | Tazminat | Sahiplik |
|---|---|---|---|---|
| President | 6.9yrs | US$1.26m | 0.26% $ 105.3k | |
| CFO, Treasurer & Secretary | less than a year | US$445.95k | 0.023% $ 9.2k | |
| Senior Vice President | 12.8yrs | US$538.31k | 1.32% $ 534.1k | |
| Executive Vice President | 5.8yrs | US$746.27k | 0% $ 0 | |
| Executive Chairman | less than a year | Veri yok | 5.04% $ 2.0m |
5.8yrs
Ortalama Görev Süresi
55yo
Ortalama Yaş
Deneyimli Yönetim: APYX 'un yönetim ekibi deneyimli ve deneyimlidir ( 5.8 yıldır).
Yönetim Kurulu Üyeleri
| İsim | Pozisyon | Görev süresi | Tazminat | Sahiplik |
|---|---|---|---|---|
| President | 6.9yrs | US$1.26m | 0.26% $ 105.3k | |
| Executive Chairman | less than a year | Veri yok | 5.04% $ 2.0m | |
| Independent Director | 13.7yrs | US$114.06k | 0.079% $ 32.2k | |
| Lead Independent Director | 13.7yrs | US$162.56k | 0.12% $ 50.2k | |
| Member of Medical Advisory Board | 5.3yrs | Veri yok | Veri yok | |
| Member of Scientific Advisory Board | no data | US$9.30k | Veri yok | |
| Member of Scientific Advisory Board | no data | Veri yok | Veri yok | |
| Independent Vice-Chairman of the Board | 10.3yrs | US$144.06k | 0% $ 0 | |
| Independent Director | 5.3yrs | US$116.56k | 0% $ 0 | |
| Independent Director | 6.7yrs | US$106.56k | 0.22% $ 90.3k | |
| Member of Medical Advisory Board | 7.8yrs | Veri yok | Veri yok | |
| Member of Medical Advisory Board | 6.5yrs | Veri yok | Veri yok |
6.8yrs
Ortalama Görev Süresi
68yo
Ortalama Yaş
Deneyimli Yönetim Kurulu: APYX 'nin yönetim kurulu üyeleri deneyimli olarak kabul edilir (ortalama görev süresi 6.8 yıldır).